Sunday, 26 October, 20:30 - 21:30 (CET)
Time zone
am/pm
24h
Suggestions
Your search did not return any results.
On behalf of Bruce Samuels, Amir Lerman, Odayme Quesada, Khaled Ziada, Francesco Giannini, Samit Shah, and Alexandra Lansky, we are pleased to invite you to the VahatiCor-sponsored symposium:
“A new generation of Coronary Sinus Reducer can expand CMD treatment options”
Sunday, 26 October, 12:30 to 1:30 PM – Scientific Abstract Station 1
Innovation & Training Hall, Hall D, Exhibition Level, Moscone South
The learning objectives are to understand:
• Reducer therapy mechanism of action for coronary microvascular dysfunction
• VahatiCor’s focus on building clinical evidence in coronary microvascular dysfunction
• A-FLUX’s innovative design
• The importance of diagnosing coronary microvascular dysfunction
On behalf of Bruce Samuels, Amir Lerman, Odayme Quesada, Khaled Ziada, Francesco Giannini, Samit Shah, and Alexandra Lansky, we are pleased to invite you to the VahatiCor-sponsored symposium:
“A new generation of Coronary Sinus Reducer can expand CMD treatment options”
Sunday, 26 October, 12:30 to 1:30 PM – Scientific Abstract Station 1
Innovation & Training Hall, Hall D, Exhibition Level, Moscone South
The learning objectives are to understand:
• Reducer therapy mechanism of action for coronary microvascular dysfunction
• VahatiCor’s focus on building clinical evidence in coronary microvascular dysfunction
• A-FLUX’s innovative design
• The importance of diagnosing coronary microvascular dysfunction
Innovation & Training Hall, Hall D, Exhibition Level, Moscone South, San Francisco, CA
Alexandra Pop, alexandra@t45labs.com